mRNA-1273 Moderna COVID-19 Vaccine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden LR, et al.〔N Engl J Med. 2021 Feb 4;384(5):403-416〕（査読済み）
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Wu K, et al. 〔bioRxiv. 2021 Jan 25;2021.01.25.427948〕（査読前）
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (correspondence)
Wu K, et al.〔N Engl J Med. 2021 Apr 15;384(15):1468-1470〕（査読済み）
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 (Correspondence)
Blumenthal KG, et al.〔N Engl J Med. 2021 Apr 1;384(13):1273-1277〕（査読済み）
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination (Research Letter)
Edara VV, et al.〔JAMA. 2021 May 11;325(18):1896-1898〕（査読済み）
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (Correspondence)
Doria-Rose N, et al.〔N Engl J Med. 2021 Apr 6〕（査読済み）
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series (Brief Report)
Johnston MS, et al.〔JAMA Dermatol. 2021 May 12〕（査読済み）